Cited 5 time in
3Cpro of FMDV inhibits type II interferon-stimulated JAK-STAT signaling pathway by blocking STAT1 nuclear translocation
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Wu, X. | - |
| dc.contributor.author | Chen, L. | - |
| dc.contributor.author | Sui, C. | - |
| dc.contributor.author | Hu, Y. | - |
| dc.contributor.author | Jiang, D. | - |
| dc.contributor.author | Yang, F. | - |
| dc.contributor.author | Miller, L.C. | - |
| dc.contributor.author | Li, J. | - |
| dc.contributor.author | Cong, X. | - |
| dc.contributor.author | Hrabchenko, N. | - |
| dc.contributor.author | Lee, C. | - |
| dc.contributor.author | Du, Y. | - |
| dc.contributor.author | Qi, J. | - |
| dc.date.accessioned | 2023-04-26T07:40:53Z | - |
| dc.date.available | 2023-04-26T07:40:53Z | - |
| dc.date.issued | 2023-06 | - |
| dc.identifier.issn | 1674-0769 | - |
| dc.identifier.issn | 1995-820X | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/59314 | - |
| dc.description.abstract | Foot-and-mouth disease virus (FMDV) has developed various strategies to antagonize the host innate immunity. FMDV Lpro and 3Cpro interfere with type I IFNs through different mechanisms. The structural protein VP3 of FMDV degrades Janus kinase 1 to suppress IFN-γ signaling transduction. Whether non-structural proteins of FMDV are involved in restraining type II IFN signaling pathways is unknown. In this study, it was shown that FMDV replication was resistant to IFN-γ treatment after the infection was established and FMDV inhibited type II IFN induced expression of IFN-γ-stimulated genes (ISGs). We also showed for the first time that FMDV non-structural protein 3C antagonized IFN-γ-stimulated JAK-STAT signaling pathway by blocking STAT1 nuclear translocation. 3Cpro expression significantly reduced the ISGs transcript levels and palindromic gamma-activated sequences (GAS) promoter activity, without affecting the protein level, tyrosine phosphorylation, and homodimerization of STAT1. Finally, we provided evidence that 3C protease activity played an essential role in degrading KPNA1 and thus inhibited ISGs mRNA and GAS promoter activities. Our results reveal a novel mechanism by which an FMDV non-structural protein antagonizes host type II IFN signaling. © 2023 The Authors | - |
| dc.format.extent | 11 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | KeAi Communications Co. | - |
| dc.title | 3Cpro of FMDV inhibits type II interferon-stimulated JAK-STAT signaling pathway by blocking STAT1 nuclear translocation | - |
| dc.type | Article | - |
| dc.identifier.doi | 10.1016/j.virs.2023.03.003 | - |
| dc.identifier.scopusid | 2-s2.0-85152540940 | - |
| dc.identifier.wosid | 001020937700001 | - |
| dc.identifier.bibliographicCitation | Virologica Sinica, v.38, no.3, pp 387 - 397 | - |
| dc.citation.title | Virologica Sinica | - |
| dc.citation.volume | 38 | - |
| dc.citation.number | 3 | - |
| dc.citation.startPage | 387 | - |
| dc.citation.endPage | 397 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Virology | - |
| dc.relation.journalWebOfScienceCategory | Virology | - |
| dc.subject.keywordAuthor | 3C | - |
| dc.subject.keywordAuthor | Foot-and-mouth disease virus (FMDV) | - |
| dc.subject.keywordAuthor | IFN-γ | - |
| dc.subject.keywordAuthor | JAK-STAT signaling pathway | - |
| dc.subject.keywordAuthor | KPNA1 | - |
| dc.subject.keywordAuthor | STAT1 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
